Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1962 3
1963 1
1964 2
1967 5
1968 3
1969 5
1970 1
1971 4
1972 1
1973 3
1974 7
1975 11
1976 2
1977 7
1978 4
1979 15
1980 11
1981 11
1982 16
1983 12
1984 8
1985 15
1986 19
1987 17
1988 24
1989 24
1990 30
1991 42
1992 46
1993 28
1994 32
1995 42
1996 31
1997 46
1998 75
1999 69
2000 106
2001 126
2002 134
2003 152
2004 203
2005 290
2006 268
2007 347
2008 434
2009 453
2010 588
2011 647
2012 754
2013 782
2014 809
2015 917
2016 1002
2017 919
2018 971
2019 1033
2020 1154
2021 1341
2022 1288
2023 1186
2024 1175
2025 1292
2026 822
2027 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

17,676 results

Results by year

Filters applied: . Clear all
Page 1
Phase 3 Results of Bepirovirsen Treatment for Chronic Hepatitis B Virus Infection.
Hou J, Lim SG, Buti M, Yuen MF, Gane E, Lampertico P, Terrault N, Nguyen H, Yim HJ, Xie Q, Lin J, Qiu Y, Jeng WJ, Heo J, Peng CY, Chen CH, Chuang WL, Xie Y, Hlebowicz M, Idriz N, Mehta R, Agarwal K, Gomes da Silva MM, Franca A, Cernat R, Leerapun A, Coffin CS, Gadano A, Andreone P, Fujiyama S, Sevastianos V, Suzuki Y, Ratziu V, Riachi G, Stocker H, Lim TH, Asselah T, Tanaka Y, Holmes J, Liang X, Cremer J, Lukić T, Plein H, Quinn G, Tao Y, Paff M, Theodore D, Elston R; B-Well Study Group. Hou J, et al. Among authors: lim sg. N Engl J Med. 2026 Jun 25;394(24):2395-2406. doi: 10.1056/NEJMoa2515131. Epub 2026 May 28. N Engl J Med. 2026. PMID: 42206582 Clinical Trial.
Type 2 diabetes mellitus.
Davies MJ, Lim S, Slater T, Goldney J, Philis-Tsimikas A, Franco DR, Lamptey R, Yates T, Tankova T, Lingvay I. Davies MJ, et al. Among authors: lim s. Nat Rev Dis Primers. 2026 Mar 19;12(1):13. doi: 10.1038/s41572-026-00687-w. Nat Rev Dis Primers. 2026. PMID: 41857071 Review.
Discontinuation of Beta-Blocker Therapy after Myocardial Infarction.
Choi KH, Kang D, Kim W, Doh JH, Kim J, Park YH, Ahn SG, Park JP, Kim SM, Cho BR, Nam CW, Cho JH, Joo SJ, Suh J, Jeong JO, Jang WJ, Goh CW, Yoon CH, Hwang JY, Lim SH, Lee SR, Shin ES, Kim BJ, Yu CW, Her SH, Kim HK, Park KT, Kim J, Kim J, Park TK, Lee JM, Cho J, Yang JH, Song YB, Choi SH, Gwon HC, Guallar E, Hahn JY; SMART-DECISION Investigators. Choi KH, et al. Among authors: lim sh. N Engl J Med. 2026 Apr 2;394(13):1302-1312. doi: 10.1056/NEJMoa2601005. Epub 2026 Mar 30. N Engl J Med. 2026. PMID: 41910427 Clinical Trial.
Amivantamab in Recurrent/Metastatic Head and Neck Squamous Cell Cancer After Checkpoint Inhibitor and Chemotherapy: Pivotal Results From the Phase Ib/II OrigAMI-4 Study.
Burtness B, Rosenberg AJ, Calderon B, Lim SM, Yang MH, Li SH, Kadowaki S, Swiecicki PL, Geiger JL, Ince W, Hahn D, Guo Y, Adkins D, Metcalf R, Ahn MJ, Sukari A, Braña I, Keam B, Tanaka H, Sheth S, Oliva M, Lyu X, Curtin JC, Toyoizumi K, Xie J, Wade M, Diorio B, Kapoor A, Yilmaz E, Baig M, Kim P, Verheijen RB, Shah S, Harrington KJ; OrigAMI-4 Cohort 1 Investigators. Burtness B, et al. Among authors: lim sm. J Clin Oncol. 2026 May 31:JCO2601042. doi: 10.1200/JCO-26-01042. Online ahead of print. J Clin Oncol. 2026. PMID: 42218660
Multi-modal AI for comprehensive breast cancer prognostication.
Witowski J, Zeng KG, Cappadona J, Elayoubi J, Choucair K, Chiru ED, Chan N, Kang YJ, Howard F, Ostrovnaya I, Fernandez-Granda C, Schnabel F, Steinsnyder Z, Ozerdem U, Liu K, Abdulsattar W, Zong Y, Daoud L, Beydoun R, Saad AM, Thakore N, Sadic M, Yeung F, Liu E, Hill T, Swett B, Rigau D, Clayburn AJ, Speirs V, Vetter M, Sojak L, Muenst S, Baumhoer D, Pan JW, Makmur H, Teo SH, Pak LM, Angel V, Zilenaite-Petrulaitiene D, Laurinavicius A, Klar N, Piening BD, Bifulco C, Jun SY, Yi JP, Lim SH, Brufsky A, Esteva FJ, Pusztai L, LeCun Y, Geras KJ. Witowski J, et al. Among authors: lim sh. Nat Commun. 2026 May 20;17(1):5879. doi: 10.1038/s41467-026-73088-y. Nat Commun. 2026. PMID: 42161927 Free PMC article.
Bnip3lb-driven mitophagy maintains fate of the embryonic hematopoietic stem cell pool.
Meader E, Walcheck MT, Leder MR, Delaney P, Falchetti M, Jing R, Li C, Kambli NK, Wrighton PJ, Sugden WW, Najia MA, Oderberg IM, Taylor VM, LeBlanc ZC, Quenzer ED, Lim SE, Schlaeger T, Daley GQ, Goessling W, North TE. Meader E, et al. Among authors: lim se. Nat Commun. 2026 Feb 24;17(1):3140. doi: 10.1038/s41467-026-69593-9. Nat Commun. 2026. PMID: 41735276 Free PMC article.
FRZB-induced anti-angiogenic effect via Caveolin-1-mediated TGFβ signalling.
Chen CJ, Zhou L, Chen HT, Barathi VA, Qiu B, Alli-Shaik A, Chia RN, Lim ST, Joo C, Cheung N, Chan CM, Koh SK, Tan A, Verma RK, Fan H, Song W, Virshup D, Gunaratne J, Wong TY, Cheung GCM, Hong W, Wang X. Chen CJ, et al. Among authors: lim st. Nat Commun. 2026 Apr 7;17(1):4947. doi: 10.1038/s41467-026-71326-x. Nat Commun. 2026. PMID: 41946692 Free PMC article.
Environmental and Social Drivers of Hidradenitis Suppurativa.
Baker NM, Santiago-Soltero K, Flores V, Lim S, de Oliveira Wafae BG, Cohen SR, Cobos G, Manjaly P, Porter ML, Orlowski G, Chen K, Barnes LA, Chang AY, Charrow AP. Baker NM, et al. Among authors: lim s. JAMA Dermatol. 2026 Jun 1;162(6):652-655. doi: 10.1001/jamadermatol.2026.0895. JAMA Dermatol. 2026. PMID: 42090176 Free PMC article.
Efficacy and Safety of Fixed-Dose Combinations of Sitagliptin and Empagliflozin as Add-On to Metformin in Korean Patients With Type 2 Diabetes: A Randomised, Double-Blind, Multi-Centre, Placebo-Controlled, Phase III Trial.
Lim S, Kim TN, Mok JO, Chung CH, Hwang YC, Cho HC, Won JC, Jeon E, Kang ES, Lee KY, Kim CH, Kwak SH, Park CY, Park KS, Kim SY, Lee JH, Lee SH, Cho DH, Kwon HS, Han KA. Lim S, et al. Diabetes Obes Metab. 2026 Jun;28(6):4847-4859. doi: 10.1111/dom.70669. Epub 2026 Mar 26. Diabetes Obes Metab. 2026. PMID: 41883295 Free PMC article. Clinical Trial.
Efficacy and safety of co-administered cagrilintide and semaglutide versus semaglutide alone in adults with overweight or obesity with or without type 2 diabetes in Japan and Taiwan (REDEFINE 5): a multicentre, randomised, active-controlled, phase 3a trial.
Yamauchi T, Becker NP, Hagemann CA, Huang KC, Kiyosue A, Lim S, Onishi Y, Kosuvaripalli A, Takano T, Ishigaki Y; REDEFINE 5 study group. Yamauchi T, et al. Among authors: lim s. Lancet Diabetes Endocrinol. 2026 Jun;14(6):450-462. doi: 10.1016/S2213-8587(25)00402-4. Epub 2026 Apr 17. Lancet Diabetes Endocrinol. 2026. PMID: 42009015 Clinical Trial.
17,676 results
You have reached the last available page of results. Please see the User Guide for more information.